PRODUCTS
ZytoDot ® 2C SPEC CDKN2A/CEN 9 Probe
The ZytoDot ® 2C SPEC CDKN2A/CEN 9 Probe is designed for the detection of CDKN2A deletions frequently observed in most tumor cell lines as well as in primary human malignancies. CDKN2A has been identified as a major susceptibility gene for melanoma. The tumor suppressor gene CDKN2A is inactivated by homozygous deletions with high frequency in a variety of human primary tumors e.g. bladder and renal cell carcinoma, non-small cell lung cancer, sarcoma, glioma and mesothelioma. Deletion of the CDKN2A gene is found in up to 80% of T-cell acute lymphoblastic leukemia cases.
Probe Maps
Ordering Information
| Prod. No.: | Tests¹ (Volume): | Intended Use²: | ||
|---|---|---|---|---|
| C-3067-400 |
|
 |
Download Information
| 1 | Using 10 μl probe solution per test. |
| 2 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
